OMRON VENTURES Co., Ltd. (CEO: Tomoko Inoue) is pleased to announce that it has made an investment in Theranica Ltd. (headquartered in Israel). Theranica develops advanced electrical neuromodulation devices for the acute treatment of migraine.

OMRON is a pioneer in the field of home medical devices. Through this investment, OMRON VENTURES aims to support innovation in the at-home treatment of historically challenging and widely prevalent pain diseases, and thereby improve the quality of life of patients wordwide.